Mission Pet Health Rollover Equity: The 2026 Partner Model Explained

Most of the practice owners who reach out after receiving a Mission Pet Health partnership term sheet have the same question. Not “is the number good?” — the number is usually the second question.

The first is: “What does ‘partner equity’ actually mean, and do I ever really get paid again?”

It’s the right question. A rollover equity offer sounds compelling in a presentation — you take cash today, stay involved, and get paid again when the platform sells.

The math works on paper. But the details buried in the definitive agreement determine whether that second bite lands as a meaningful check or a disappointing footnote.

I’ve sat with enough practice owners reviewing these structures to know where the confusion lives. It almost always comes down to three things: where the equity actually sits, how the put/call mechanism is written, and whether anyone else was invited to bid before the seller said yes.

Mission Pet Health rollover equity is the portion of a practice sale kept as ownership in the Mission platform or practice entity rather than taken as cash at closing. It defers tax on that retained amount and creates a potential second payout when Mission Pet Health’s sponsor, Shore Capital, eventually recapitalizes or exits.

The specific terms of any Mission Pet Health offer are negotiated case by case and become visible through a competitive process.

Key takeaways

• Mission Pet Health is the combined entity of Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP) — merger closed December 2024, new brand launched July 2025, backed by Shore Capital and Silver Lake. As of mid-2026, the platform operates 930+ locations across 41 states.
• The partnership or co-ownership model is Mission’s signature deal approach — sellers typically receive cash at closing for the majority portion and retain a meaningful equity stake in the practice or platform, with a put/call mechanism defining the second liquidity event.
• Rollover equity that is properly structured is tax-deferred at closing — the seller pays no tax on the retained portion until the next exit, and the gain at exit generally qualifies for long-term capital gains treatment rather than ordinary income rates.
• The real value of the retained equity depends on where it sits — practice-level (OpCo) equity vs. platform-level (TopCo) equity carry different risk profiles and different upside trajectories.
• A single partnership offer is one data point — the structure and value of any Mission Pet Health term sheet only becomes clear when compared against competing bids from other qualified buyers in the same structured process.

What Mission Pet Health is in 2026 — and why it matters for sellers

Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP) merged in December 2024, creating what is now one of the largest veterinary platforms in the United States. The combined organization publicly launched its unified Mission Pet Health brand on July 21, 2025, under the leadership of CEO Dr.

Jay Price, the veterinarian who founded SVP in 2014 in Birmingham, Alabama.

The platform’s PE sponsor is Shore Capital Partners, a Chicago-based private equity firm focused on healthcare services. Silver Lake, a global technology and healthcare investor, provided a substantial capital infusion alongside the merger, which valued the combined entity at approximately $8.6 billion.

As of May 2026, Mission Pet Health operates more than 930 locations across the country — spanning 41 states — and its property portfolio is large enough that Four Corners Property Trust agreed in May 2026 to acquire up to 102 Mission veterinary properties for up to $268 million from Shore Capital Real Estate Partners Fund I.

That scale matters if you’re a selling vet, for two reasons. First, Mission is among the most active acquirers in the current market — it has the capital and the appetite to move quickly.

Second, a buyer this large brings institutional deal infrastructure: term sheets, legal teams, and acquisition playbooks that have been refined across hundreds of transactions.

Neither fact means you should accept the first offer. It means you should understand exactly what that offer is structured to accomplish — for them and for you.

How the Mission Pet Health partnership model works in 2026

The deal structure that Mission Pet Health — and its SVP legacy before it — is most associated with is the partnership or co-ownership model. Rather than buying 100 percent of the practice outright, Mission typically acquires a majority stake and the selling veterinarian retains a meaningful ownership position, either at the practice level or in the broader platform.

Rollover equity — keeping a slice of ownership in the new entity instead of taking all cash at close — is what makes this a “partnership” rather than an outright sale. The seller becomes a co-owner in the combined vehicle and participates in the platform’s appreciation until the next liquidity event.

The architecture usually looks like this:

Component	What it means
Cash at close	The majority of deal value, paid as a wire to the seller at the closing date. Taxed immediately at capital gains rates on the seller’s gain.
Retained equity (OpCo or TopCo)	The seller’s ongoing ownership stake — either in the individual practice entity (OpCo) or in the parent holding company (TopCo). Tax-deferred until exit.
Put/call mechanism	The contractual right that defines when and at what formula price the retained stake is bought out at the next liquidity event.
Earnout (if applicable)	An additional contingent payment tied to the practice hitting defined performance targets post-closing. Taxed as ordinary income in most structures.

The put/call mechanism deserves plain-English explanation. The “call” gives Mission the right to buy the seller’s remaining stake at a formula price on a defined future date — often year 3 to year 5 post-closing.

The “put” gives the seller the right to require Mission to buy that same stake, under the same formula, on the same timeline. Together, they fix the runway for the second liquidity event and the formula by which the retained equity is valued at exit.

What that formula is, and when exactly it triggers, are negotiated at closing. The formula is among the most important terms in the entire document — more consequential for most sellers than the headline purchase price, because it determines what the “second bite” actually pays.

What OpCo equity and TopCo equity actually mean

This is where most partnership-model conversations lose people. Two sellers can each “keep 20 percent” and end up with very different economic outcomes depending on where that 20 percent sits.

OpCo equity is ownership retained at the individual practice level — the seller keeps a stake in their own hospital entity within the Mission network. The value of that stake rises or falls with the specific practice’s performance.

It’s simpler to understand and to negotiate, and it keeps the seller’s economic exposure closer to what they know and control.

TopCo equity is ownership in the parent holding company of the Mission Pet Health platform itself — the entity whose value reflects the combined performance of all 930-plus locations. If the whole platform appreciates materially between now and Shore Capital’s next exit, the seller’s TopCo stake goes up accordingly.

The upside can be larger in absolute terms. But the seller also absorbs platform-level risk — performance of hospitals they’ve never met, integration costs, capital structure changes at the holding company — that they can’t control.

Most Mission partnership offers blend components of both. The mix, the valuation methodology used to price the retained equity at close, and the governance rights that come with the stake are all points of negotiation. They are not fixed.

The second bite — and what makes it real versus theoretical

The phrase “second bite of the apple” refers to the second payout a seller receives when the PE sponsor exits the platform. In theory, it works like this: you sell 70 percent of a $10 million practice at closing, receive $7 million in cash, and retain 30 percent — $3 million worth of equity in the platform.

When Shore Capital exits in year 4 or 5, if the platform has grown and the overall valuation is meaningfully higher, your 30 percent stake is worth more than $3 million. The upside from that appreciation is your second bite.

Whether that second bite materializes depends on factors that matter enormously and are worth asking about directly.

Where is Shore Capital in its fund lifecycle? PE firms raise funds with fixed terms — typically 10 years, with the first 4 or 5 years for deploying capital and the back half for managing and exiting investments. If Shore Capital’s investment in the Mission platform is 3 years old at closing, the exit timeline is more defined than if the investment is 6 years old.

Sellers with rollover equity generally want to know: when is the pressure to exit, and what does that mean for the valuation environment at exit?

What recapitalization environment will greet the exit? The SVP/MVP merger itself closed in December 2024 and was the first significant recapitalization in the large veterinary platform space in roughly 2.5 years, according to market commentary at the time. Subsequent platforms that tested the recapitalization market in 2025 were unable to achieve valuations that satisfied their investors, per publicly available M&A commentary. The exit environment at the time Shore Capital chooses to move is not known today. A seller accepting rollover equity is making an implicit bet that the market at exit will be at least as favorable as today’s.

What are the performance obligations tied to the retained equity? Rollover equity stakes are frequently subject to vesting schedules or performance conditions tied to the seller’s continued involvement. A stake that vests over 3 years provides less protection than one that is fully vested at close. Read that section of the agreement carefully before assuming the retained equity is unconditional.

The tax picture for rollover equity sellers in 2026

The tax treatment of rollover equity is one of the genuine advantages of the partnership model — when the deal is properly structured.

Properly structured rollover equity receives tax-deferred treatment at closing. The seller pays no income tax on the retained portion at the time of the transaction. Only the cash component received at close triggers immediate tax, typically at long-term capital gains rates on the gain over cost basis.

The deferred portion is taxed when the seller ultimately exits — at the next recapitalization or platform sale. At that future exit, the gain on the rollover generally qualifies for long-term capital gains treatment rather than ordinary income rates, provided the seller has held the equity long enough and the structure is maintained correctly.

The maximum long-term capital gains rate is 20 percent federally, compared to 37 percent for ordinary income.

A few cautions that every vet considering a rollover should hear from their CPA before signing:

Earnouts — the performance-contingent component of a deal — are taxed as ordinary income in most structures, not capital gains. If a Mission offer includes an earnout component alongside the rollover equity, those two components are taxed differently.

Quarterly distributions from a partnership interest are taxed as ordinary income. If the retained equity comes in the form of partnership units that pay distributions during the hold period, those distributions don’t get capital gains treatment.

The entity structure of the deal matters for tax deferral. Section 721 of the Internal Revenue Code allows tax-deferred rollover treatment for contributions to a partnership — but the acquiring entity must qualify. If the structure involves an S corporation or C corporation at the receiving entity level, the tax treatment may differ. Work with a CPA who has closed multiple veterinary practice transactions, not one doing it for the first time.

What Mission says about how it operates — and what that means for sellers

Mission Pet Health‘s published partnership philosophy, per its own materials and the July 2025 brand launch announcement, is built around three stated commitments: medical autonomy for the veterinary team, local brand and culture preservation (the practice name doesn’t change), and operational support that lets the clinical team focus on medicine rather than administration.

In the press release announcing the Mission Pet Health brand, Dr. Jay Price described the organization’s founding belief as: “veterinarians and their teams deserve medical autonomy alongside the best support and resources.”

Those commitments are meaningful to the right seller — particularly one whose primary concern is preserving the practice identity and culture they’ve built. Verifying how those commitments translate into the definitive purchase agreement is the seller’s job. Published brand values and legal documentation are not the same thing. Brand-preservation language should be explicit in the contract, including the practice name, signage, website, and marketing materials.

The same principle applies to every term in the offer. Mission Pet Health’s acquisition team is professional, capital-equipped, and experienced.

They have closed hundreds of transactions. The terms they bring to the table are the ones their model has optimized over time.

The seller’s job — and the job of whoever represents the seller — is to understand exactly what those terms mean, compare them against what other buyers would offer, and negotiate the points that matter most.

Whether to partner or run a process — the question every seller has to answer

The argument Mission Pet Health‘s acquisition team will make is consistent: partnering directly means certainty, speed, and a collaborative relationship with a group that has a strong track record on medical autonomy.

Those points are worth taking seriously. They’re also not the same as “this is the best outcome you could achieve.”

The specific structure and value of any Mission Pet Health partnership offer become visible only when compared against other buyers bidding under the same conditions. A direct conversation with Mission is a single data point. The only way to know what your practice is actually worth — and what the best available deal structure looks like — is to put it in front of multiple qualified buyers through a structured, competitive process.

That’s what our Elite Selling System is built to do. We hand-select and vet every buyer who gets to bid on a practice — the way a doorman with a velvet rope lets in only the right people.

Inside that qualified buyer pool, we run a private competitive bidding window that creates real leverage. Mission Pet Health is a credible, well-resourced buyer that participates in those processes.

So are a dozen other institutional buyers, each with their own deal structure preferences.

The owner who sits across from Mission Pet Health‘s acquisition team without knowing what anyone else would pay is making a decision with incomplete information. The owner who enters that same conversation having already seen competing bids is negotiating from a completely different position.

Rollover equity only rewards you if the platform appreciates. The cash-at-close component — the part that wires to you on the day of closing — is locked in the moment you sign. Running a competitive process is how you know whether that number, and the equity terms alongside it, are the best available.

Across the deals we’ve closed over the past four-plus years, the gap between a direct-offer outcome and a competitive-process outcome on the same practice consistently runs into meaningful dollars — often more than any rollover upside could recover, regardless of how the platform performs.

The math on that gap is worth understanding before you agree to any partnership structure.

Get a Free Practice Value Estimate →

If you’ve received a Mission Pet Health partnership term sheet — or you’re expecting one — the most useful thing you can do right now is understand what your practice is worth to the full buyer pool, not just to one buyer. That’s what the free estimate gives you: a clear, no-obligation read on where your practice stands in the current market, before any conversation goes further.

Transitions Elite works on a success-based basis. We get paid only when a deal closes, and only out of the value created above what the seller would have realized on their own.

There are no upfront fees and no retainer.

---

Frequently asked questions

What is Mission Pet Health rollover equity in 2026?

Mission Pet Health rollover equity is the portion of a practice sale price that a selling veterinarian keeps as ownership in the Mission Pet Health platform or practice entity rather than receiving as cash at closing. The seller defers tax on the rolled-over amount and receives a second payout — the second bite — when Mission Pet Health or its PE sponsor Shore Capital recapitalizes or exits the platform.

The specific structure and terms of any Mission Pet Health offer are negotiated case by case and become visible through a competitive process.

How does the Mission Pet Health partnership model work in 2026?

Mission Pet Health — the combined platform of Southern Veterinary Partners and Mission Veterinary Partners, launched July 2025 and backed by Shore Capital — uses a partnership or co-ownership model as its signature deal approach. The buyer typically acquires a majority stake in the practice while the selling veterinarian retains a meaningful equity position, with a put/call mechanism defining when and how that retained stake is bought out.

The seller receives cash at close for the majority of the deal value, stays involved as a partner, and participates in the platform’s appreciation until the next liquidity event.

What is the “second bite of the apple” in a Mission Pet Health deal?

The second bite of the apple refers to the second liquidity event that a seller receives when Mission Pet Health or Shore Capital recapitalizes or exits the platform. At the first closing, the seller receives cash for the majority portion of the deal.

The retained equity — the rollover — sits in the platform and grows (or shrinks) with the platform’s performance. When the PE sponsor exits, often through a recapitalization or sale to another buyer, the seller’s retained stake is purchased at whatever the platform is worth at that moment.

Is rollover equity in a Mission Pet Health deal taxed at closing?

Rollover equity that is properly structured receives tax-deferred treatment at closing — the seller pays no income tax on the retained portion at the time of the transaction. Tax is deferred until the seller ultimately exits the retained equity stake, typically at the next recapitalization or platform sale.

At that future exit, the gain on the rollover is generally taxed as long-term capital gains rather than ordinary income, though the exact treatment depends on how the deal is structured and the seller’s specific tax situation. Always consult a CPA experienced in veterinary practice transactions.

What is the difference between OpCo equity and TopCo equity in a veterinary practice sale?

OpCo equity is ownership retained at the individual practice level — the seller keeps a stake in their own hospital entity within the group. TopCo equity is ownership in the parent holding company of the PE-backed platform — the entity whose value reflects the combined performance of all the hospitals in the group.

OpCo equity is simpler to value but grows only with the individual practice’s performance. TopCo equity grows with the whole platform and typically produces a larger absolute payout at exit if the platform appreciates, but carries platform-level risk.

How big is Mission Pet Health in 2026?

Mission Pet Health is one of the largest veterinary networks in the United States as of 2026, operating more than 930 locations across the country. It was formed through the merger of Southern Veterinary Partners and Mission Veterinary Partners, which closed in December 2024, with the new unified brand publicly launched on July 21, 2025.

The platform is backed by Shore Capital Partners as primary PE sponsor and received a substantial capital infusion from Silver Lake during the merger.

Should I take a Mission Pet Health partnership offer or run a competitive process?

The specific structure and value of any Mission Pet Health offer become clear only when compared against other buyers bidding under the same conditions. Owners considering a Mission Pet Health partnership term sheet benefit from running a competitive process with multiple qualified bidders — that is the only way to know whether the partnership terms, the equity value, and the cash-at-close component represent the best available outcome for the practice.

A single-buyer conversation is a single data point.

What questions should I ask before accepting rollover equity in a veterinary practice deal?

Before accepting rollover equity in any veterinary practice deal, ask: At what valuation is my retained equity priced at the time of this closing? What is the put/call mechanism — when can I force or be forced into the buyout, and at what formula?

Is my equity at the practice level (OpCo) or the platform level (TopCo)? What are the governance rights that come with the retained stake?

What performance obligations are tied to keeping the equity — and what happens if I fall short? When did the PE sponsor first invest, and where are they in their fund lifecycle?

Each of these affects the real value of the retained equity.

---

More on Selling to Mission Pet Health

• Selling your practice to Mission Pet Health
• Mission Pet Health vs. NVA vs. Mars
• Offer and deal structure
• How to evaluate a Mission Pet Health offer
• Got an offer from Mission Pet Health

Sources

Industry M&A research and valuation data

1. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
2. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion; VSOs Under Increasing Pressure.” 2025. octus.com
3. Today’s Veterinary Business. “The Great Compression, Year 3.” December 2025. todaysveterinarybusiness.com

Public company disclosures and PE filings

4. Mission Pet Health. “Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health.” Press release, July 21, 2025. missionpethealth.com
5. GlobeNewswire. “Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health.” July 21, 2025. globenewswire.com
6. Shore Capital Partners. “Mission Pet Health.” Portfolio page. shorecp.com
7. Silver Lake. “Mission Pet Health.” Portfolio page. silverlake.com
8. Four Corners Property Trust (FCPT). “FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million.” BusinessWire, May 2026. businesswire.com
9. Mission Pet Health. “Partnerships.” missionpethealth.com/partnerships/

Legal and regulatory analysis

10. Koley Jessen. “Rollover Equity: An Overview of Tax-Deferred Structures.” koleyjessen.com
11. Forchelli Deegan Terrana Law. “Introduction to Rollover Equity.” forchellilaw.com
12. Mahan Law. “Tax-Saving Strategies in Veterinary Practice Transitions.” mahanlaw.com

Veterinary practice operations, benchmarks, and profession data

13. dvm360. “Merger of veterinary organizations yields a new name.” 2025. dvm360.com
14. dvm360. “What Uncle Sam gets when you sell your practice.” dvm360.com